FDA Change Impact Assessment for Medical Devices
Assess device changes before they create FDA exposure. Elexes helps medical device manufacturers evaluate design, software, labeling, material, and process modifications against FDA expectations, document a defensible rationale, and determine whether a new 510(k), PMA supplement, or no submission is appropriate. Get clarity that protects market access and supports compliant change control.
Our FDA Change Impact Assessment Services
Targeted regulatory support for evaluating device changes, submission obligations, and supporting documentation.
Change Assessment
Structured evaluation of design, software, labeling, material, manufacturing, and intended use changes to determine whether FDA notification or a new submission is required.
510(k) Strategy
Regulatory analysis to determine whether a modification fits existing clearance or requires a Special, Traditional, or other 510(k) pathway.
Submission Readiness
Gap-based review of documentation, risk files, and technical evidence so your team can support change decisions with complete, audit-ready records.
Pre-Sub Support
Preparation for FDA interactions when a change raises pathway, testing, or evidence questions that benefit from early agency feedback.
Agency Responses
Support for responding to FDA questions, deficiency letters, and follow-up requests tied to modified devices or change-related submissions.
RMF/DHF Remediation
Focused remediation of risk management and design history documentation to strengthen traceability and defend change control decisions.
Our FDA Change Review Process
Review the Proposed Device Change
We start by defining the exact modification, including what changed, why it changed, and which product, process, software, labeling, or material elements are affected.
Map Regulatory Impact and Risk
Our consultants assess the change against FDA guidance, device classification, cleared indications, risk controls, and supporting evidence to identify whether safety or effectiveness could be affected.
Determine Submission Requirements
We evaluate whether the change can remain under the existing authorization or whether it triggers a new 510(k), PMA supplement, letter-to-file rationale, or another regulatory action.
Document the Regulatory Rationale
You receive a structured, defensible assessment that captures the change description, regulatory logic, evidence reviewed, and recommended next steps for internal approval and audit readiness.
Support Implementation or Submission
If further action is needed, Elexes can help with remediation, testing strategy, submission planning, or FDA correspondence so the change moves forward compliantly.
Trusted By Manufacturers
Success Stories
See how regulated device teams reduce uncertainty and move changes forward with confidence.
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Highly recommend Elexes! They always meet commitments and follow through on action items.”
Joshua Mink
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Highly recommend Elexes! They always meet commitments and follow through on action items.”
Joshua Mink
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Highly recommend Elexes! They always meet commitments and follow through on action items.”
Joshua Mink
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
The Elexes Difference
Why Choose Elexes?
Manufacturers rely on Elexes for disciplined regulatory judgment and practical execution.
Deep Expertise
50+ years of collective experience across FDA, ISO, EU MDR, and global device frameworks.
End-to-End
Support spans assessment, remediation, submission strategy, authority response, and post-approval compliance continuity.
Proven Results
250+ successful projects across 200+ product types with a 90% audit clearance rate.
Flexible Delivery
Project-based, part-time, or embedded RAQA support without adding permanent internal headcount.
Meet The Elexes Team
Experienced regulatory specialists for complex device changes.
Elexes Medical Consulting Pvt. Ltd. supports medical device manufacturers with practical, high-stakes regulatory and quality consulting across the full product lifecycle. The company has become a trusted partner for organizations navigating FDA submissions, global market access, quality system alignment, and post-market obligations. Backed by 50+ years of collective experience, the Elexes team brings cross-functional expertise in regulatory strategy, technical documentation, risk management, and audit readiness. Their approach is structured, evidence-driven, and built to reduce costly rework, prevent avoidable deficiencies, and keep products moving toward approval or continued market access. From startups to established manufacturers, Elexes helps teams make defensible regulatory decisions with clarity, speed, and confidence.
250+ ProjectsSuccessful regulatory and compliance engagements completed200+ Product TypesExperience across diverse medical device categories90% Audit ClearanceStrong inspection and audit readiness outcomes
Frequently Asked Questions
What is Section 513 G of the FD&C Act?
Section 513(g) of the FD&C Act allows a manufacturer to request FDA’s views on the classification and regulatory requirements that may apply to a medical device. It is commonly used when a company needs clarity on device classification, applicable regulations, or the likely premarket pathway. A 513(g) response is informative, but it is not a clearance or approval.
What is the timeline for 513g?
FDA’s target timeline for responding to a 513(g) request is generally 60 days after receipt, although actual timing can vary depending on agency workload and the completeness of the submission. A well-prepared request with a clear device description, intended use, and supporting rationale helps reduce avoidable delays and improves the usefulness of the response.
What is an FDA change impact assessment for medical devices?
An FDA change impact assessment is a structured review of a modification to an already cleared or approved device to determine whether the change affects safety, effectiveness, intended use, or regulatory status. It evaluates design, software, labeling, materials, manufacturing, and process changes against FDA guidance and documents whether a new submission, supplement, or internal justification is appropriate.
When does a medical device change require a new 510(k)?
A new 510(k) may be required when a change could significantly affect the device’s safety or effectiveness, or when there is a major change in intended use. Common triggers include significant software modifications, design changes affecting performance, new materials, revised sterilization methods, or labeling changes that alter indications or claims. A documented assessment is essential before implementation.
Can labeling or IFU updates trigger FDA submission requirements?
Yes. Labeling and IFU changes can trigger FDA action if they alter intended use, indications, contraindications, warnings, operating parameters, or performance claims. Even when no new submission is required, the rationale should still be documented within change control records. Careful review helps prevent introducing claims or instructions that exceed the scope of the existing clearance or approval.
What documents are reviewed during a change impact assessment?
Typical inputs include the current clearance or approval, device description, intended use statements, risk management files, verification and validation data, software documentation, labeling, design history records, complaint or PMS data, and change control records. Reviewing these materials together helps establish whether the modification remains within the existing regulatory basis or requires additional FDA engagement.
How long does a change impact assessment usually take?
The timeline depends on the complexity of the device, the number of affected markets, and the quality of the existing documentation. Straightforward labeling or administrative changes may be assessed quickly, while software, design, or manufacturing changes often require deeper review of testing, risk, and traceability records. A structured assessment upfront usually saves far more time than correcting a weak decision later.
Why should manufacturers document changes even if no new submission is needed?
Documenting the rationale is critical because FDA inspectors and auditors expect to see evidence that changes were evaluated systematically before implementation. A complete record shows what changed, what guidance was applied, what evidence was reviewed, and why the company concluded that no new submission was required. That documentation protects the business during inspections, audits, and future submissions.
Still Have Questions About Device Changes?
Talk with regulatory experts about your FDA change decision.
Certified & Trusted
Awards and Recognition
ISO 13485
Medical device quality systems expertise
MDSAP
Multi-market audit readiness support
IEC 62304
Software lifecycle compliance expertise
